Eventide Asset Management, LLC Blueprint Medicines Corp Transaction History

Eventide Asset Management, LLC

$5.22 Billion
Q4 2024

A detailed history of Eventide Asset Management, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Eventide Asset Management, LLC holds 862,285 shares of BPMC stock, worth $79.5 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares

862,285

Previous 348,704 147.28%

Holding current value

$79.5 Million

Previous $32.2 Million 133.27%

% of portfolio

1.44%

Previous 0.57%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$82.48 - $101.39 $42.4 Million - $52.1 Million	513,581 Added 147.28%	862,285 $75.2 Million
Q3 2024 Nov 14, 2024	BUY	$84.1 - $120.5 $9.84 Million - $14.1 Million	117,019 Added 50.51%	348,704 $32.2 Million
Q1 2024 May 15, 2024	SELL	$73.17 - $99.79 $5.9 Million - $8.05 Million	-80,689 Reduced 25.83%	231,685 $22 Million
Q4 2023 Feb 14, 2024	SELL	$43.96 - $92.84 $5.54 Million - $11.7 Million	-126,126 Reduced 28.76%	312,374 $28.8 Million
Q2 2022 Aug 15, 2022	SELL	$45.23 - $70.15 $6.97 Million - $10.8 Million	-154,000 Reduced 25.99%	438,500 $22.1 Million
Q1 2022 May 16, 2022	BUY	$54.1 - $110.08 $10.6 Million - $21.7 Million	196,700 Added 49.7%	592,500 $37.8 Million
Q4 2021 Feb 14, 2022	BUY	$94.25 - $115.99 $3.75 Million - $4.62 Million	39,800 Added 11.18%	395,800 $42.4 Million
Q3 2021 Nov 15, 2021	SELL	$80.98 - $109.47 $8.56 Million - $11.6 Million	-105,712 Reduced 22.9%	356,000 $36.6 Million
Q2 2021 Aug 16, 2021	SELL	$82.78 - $101.0 $23,840 - $29,088	-288 Reduced 0.06%	461,712 $40.6 Million
Q1 2019 May 15, 2019	BUY	$48.7 - $86.6 $2.44 Million - $4.33 Million	50,000 Added 12.14%	462,000 $37 Million
Q4 2018 Feb 14, 2019	BUY	$45.57 - $74.26 $5.92 Million - $9.65 Million	130,000 Added 46.1%	412,000 $22.2 Million
Q3 2018 Nov 14, 2018	BUY	$58.91 - $78.32 $7.78 Million - $10.3 Million	132,000 Added 88.0%	282,000 $22 Million
Q4 2017 Feb 14, 2018	SELL	$62.91 - $88.32 $5.41 Million - $7.6 Million	-86,000 Reduced 36.44%	150,000 $11.3 Million
Q3 2017 Nov 14, 2017	BUY	$42.37 - $69.67 $10 Million - $16.4 Million	236,000	236,000 $16.4 Million

Others Institutions Holding BPMC

# of Institutions

380

Shares Held

65.9M

Call Options Held

1.6M

Put Options Held

1.41M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.51B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.

Account

Eventide Asset Management, LLC Blueprint Medicines Corp Transaction History